NaranjoCABustoUSellersEMSandorPRuizIRobertsEA. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981; 30: 239–45.
2.
World Health Organization international database on line. INTDIS (International Drug Information System). Uppsala, Sweden: WHO Collaborating Centre for International Drug Monitoring.
3.
PerssonMVitolsSYueQY. Orlistat associated with hypertension. BMJ2000; 321: 87.
MeliaATMulliganTEZhiJ. Lack of effect of orlistat on the bioavailability of a single dose of nifedipine extended-release tablets (Procardia XL) in healthy volunteers. J Clin Pharmacol1996; 36: 352–5.
6.
WeberCTamYKSchmidtke-ScherezenmeGJonkmannJHGvan BrummelenP. Effect of the lipase inhibitor orlistat on the pharmacokinetics of four different antihypertensive drugs in healthy volunteers. Eur J Clin Pharmacol1996; 51: 87–90.